(Q39448091)

12 September 2017

title

Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening (English)

1 reference

12 September 2017

1 reference

Urban N

1

1 reference

12 September 2017

Drescher C

series ordinal

2

1 reference

12 September 2017

Etzioni R

series ordinal

3

1 reference

12 September 2017

Colby C

series ordinal

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Contemporary Clinical Trials

12 September 2017

published in

1 reference

12 September 2017

volume

18

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

251-270

1 reference

Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Quantifying the potential benefit of CA 125 screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Multimodal approach to screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Transabdominal ultrasound screening for early ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Transabdominal ultrasound screening for early ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Transabdominal ultrasound screening for early ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Coordinate elevation of serum markers in ovarian cancer but not in benign disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

The CA 125 tumour-associated antigen: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Choosing sample sizes to maximize expected health benefits subject to a constraint on total trial costs.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Validation of a model of breast cancer screening: an outlier observation suggests the value of breast self-examinations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

The Women's Health Trial as an investment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Using economic analysis to determine the resource consequences of choices made in planning clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Use and misuse of the term "cost effective" in medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Elevation of multiple serum markers in patients with stage I ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Novel screening strategies for early ovarian cancer by transabdominal ultrasonography.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Estimating the costs attributable to a disease with application to ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

A multidisciplinary approach to the early detection of ovarian carcinoma: rationale, protocol design, and early results

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

Estimates of lead time and length bias in a breast cancer screening program.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900233-4

7 January 2021

10.1016/S0197-2456(96)00233-4

Identifiers

DOI

1 reference

12 September 2017

1 reference